BMRN

BioMarin Pharmaceutical specializes in developing and commercializing transformative therapies for patients with rare and ultra-rare genetic diseases. Its portfolio focuses on enzyme replacement therapies and gene therapies that address severe unmet medical needs. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?